3. Frederic Sallmann:Intrapreneurship - Corporate innovation - TSD 17
•Transferir como PPTX, PDF•
0 gostou•249 visualizações
Tech Startup Day 2017
Recomendados
Recomendados
Mais conteúdo relacionado
Destaque
Destaque (19)
Semelhante a 3. Frederic Sallmann:Intrapreneurship - Corporate innovation - TSD 17
Semelhante a 3. Frederic Sallmann:Intrapreneurship - Corporate innovation - TSD 17 (20)
Mais de StartUps.be
Mais de StartUps.be (9)
Último
Último (20)
3. Frederic Sallmann:Intrapreneurship - Corporate innovation - TSD 17
- 1. Intrapreneurship – Corporate Innovation GSK vaccines Frederic R. Sallmann, PhD, MBA Director, Head of Innovation Management GSK vaccines
- 2. Mission 2 Be more efficient Technology Portfolio Building Process GSK Technology Marathon Innovation Strategic Objectives GSK 3D-Printing Club Confidential: For internal GSK use only Short term “secure sustainability ” Long Term “build our leadership” To Enable GSK vaccines’ Stakeholders to be as Effective and Efficient as possible in Delivering on their Innovation Objectives. GSK vaccines Strategic Objectives
- 3. The GSK Technology Marathon – 2015 – Pilot Edition 4 External Experts Commercial companies Tech- Marathonians 28 ideas posted ar. 150 participants 15 ideas pre-selected 3 projects selected
- 4. Mission 4 Be more efficient Generate New Business Model Technology Portfolio Building Process GSK Technology Marathon GSK vaccines Innovation Game Innovation Strategic Objectives Seek synergy among the 3 RDC GSK vaccines Collective Intelligence Platform GSK 3D-Printing Club Confidential: For internal GSK use only Short term “secure sustainability ” Long Term “build our leadership” Short term “secure sustainability ” Long Term “build our leadership” GSK-incubator Enable Radical innovation To Enable GSK vaccines’ Stakeholders to be as Effective and Efficient as possible in Delivering on their Innovation Objectives. GSK vaccines Strategic Objectives
- 5. The GSK Innovation Game – 2015 – Third edition ExpertsInvestors BUSINESS ANGELS Intrapreneurs 40% Faculty of Sciences 40% School of Medicine 20% Business School 27 projects 5 projects 256 participants 68 participants 849 investments Universities expressing interest MIT, Harvard, Cambridge university, ESCP EU, IIT 10.5% of participants 7.4% of participants 3 MONTHS
- 6. Thank you for your attention… ….any question?
Notas do Editor
- Around 150 participants (GSK R&D and QA BELGIUM ONLY - Pilot) 28 ideas posted by GSK employees ONLY/ 15 top pre-selected based on GSK employees’ votes, then after 2-days workshop co-selection of 10 with external experts partners (fit for GSK needs but also External expert partners’ interests) and set up of working teams made of GSK + Partner’s staff – 1 month coaching (lean-startup process) for development of a PRETOTYPE selection of 4 out of the 10 by GSK experts and Partners’ experts – 4 go for a final race during which development of first PROTOTYPE (functional or non-functional) + strengthen BC GSK (ONLY) Innovation board select project(s) for investment for further implementation in our incubator. IDEAS from GSK INCUBATION GSK + Partner SELECTION GSK DEVELOPMENT (implementation) GSK + PARTNER(S) – Resources (time + staff + money) BENEFITS GSK (WW exclusivity in Vaccine industry) + Partner(s) (WW exclusivity outside vaccine Industry)
- Participants: 86% GSK and 14% NUS Intrapreneurs: 84% GSK and 16% NUS